Trends and characteristics of pethidine use in Taiwan: A six-year-long survey

Clinics

Volumn 67, Issue 7, 2012, Pages 749-755

  Pan, Hsueh Hsing ^a,b   Li, Chung Yi ^c,d   Lin, Tso Chou ^b   Wang, Ju O ^a   Ho, Shung Tai ^b,e   Wang, Kwua Yun ^a,e  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Consumption; Defined daily dose; Pethidine; Population based; Prescription

Indexed keywords

NARCOTIC ANALGESIC AGENT; PETHIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; PUBLIC HEALTH; STATISTICS; TAIWAN; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MEPERIDINE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; TAIWAN; YOUNG ADULT;

EID: 84867088919     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(07)08     Document Type: Article

References (35)

1. Costantini R, Affaitati G, Fabrizio A, Giamberardino MA. Controlling pain in the post-operative setting. Int J Clin Pharmacol Ther. 2011;49(2):116-27.
2. Panda M, Desbiens N, Doshi N, Sheldon S. Determinants of prescribing meperidine compared to morphine in hospitalized patients. Pain. 2004; 110(1-2):337-42, http://dx.doi.org/10.1016/j.pain.2004.04.016.
3. Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9(1):53-68, http://dx.doi.org/10.1097/00045391-200201000-00010.
4. Todd M. Meperidine and the management of pain: what you need to know. Lippincotts Case Manag. 2004;9(5):241-2.
5. Vermeulen LC, Bollinger KA, Antonopoulos J, Meek PD, Goshman LM, Ploetz PA. Multifaceted approach to medication use policy development: the restriction of meperidine. Pharm Pract Manag Q. 1997;16(4):66-75.
6. Kredo T, Onia R. Pethidine-does familiarity or evidence perpetuate its use? S Afr Med J. 2005;95(2):100-1.
7. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96(4):1266-72, http://dx.doi.org/10.1111/j. 1572-0241.2001.03536.x.
8. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA. 1995;274(22):1874-80.
9. O'Callaghan JP. Evolution of a rational use of opioids in chronic pain. Eur J Pain. 2001;5(Suppl A):21-6, http://dx.doi.org/10.1053/eujp.2001.0275.
10. Kornitzer BS, Manace LC, Fischberg DJ, Leipzig RM. Prevalence of meperidine use in older surgical patients. Arch Surg. 2006;141(1):76-81, http://dx.doi.org/10.1001/archsurg.141.1.76.
11. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 2008;64(4):411-5.
12. Ponizovsky AM, Marom E, Zeldin A, Cherny NI. Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol. 2011; 67(2):165-8, http://dx.doi.org/10.1007/s00228-010-0932-0.
13. Hsu CC, Li JH. The trends of requirements in medical opioid analgesics from 1987 through 1996 in Taiwan. Chinese Journal of Public Health. 1998;17:495-503.
14. Pellegrini JE, Paice J, Faut-Callahan M. Meperidine utilization and compliance with Agency for Health Care Policy and Research guidelines in a tertiary care hospital. CRNA. 1999;10(4):174-80.
15. Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003;74(2):102-12, http://dx.doi.org/10.1016/S0009-9236(03)00152-8.
16. Pan HH, Ho ST, Lu CC, Wang JO, Lin TC, Wang KY. Trends in the consumption of opioid analgesics in Taiwan from 2002 to 2007: a population-based study. J Pain Symptom Manage. 2012. (In press)
17. Food and Drug Administration, Department of Health, Taiwan. Physician Guidelines on Clinical Use of Pethidine. 2011. Available at: http://www.fda.gov.tw/people_laws_list.aspx?classifysn = 183.
18. Lu JFR, Hsiao WC. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Affairs (Millwood). 2003;22(3):77-88, http://dx.doi.org/10.1377/hlthaff.22.3.77.
19. Directorate-General Budget, Accounting and Statistics. National Statistics of Regional Standard Classification Data. Taipei: Accounting and Statistics; 1993.
20. WHO. WHO Collaborating Centre for Drug Statistics Methodology. Complete ATC index 2010. Available at: http://www.whocc.no/atcddd/.
21. Department of Statistics. Statistical yearbook of interior. 2009. Available at: http://sowf.moi.gov.tw/stat/year/list.htm.
22. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28(2):176-88, http://dx.doi.org/10.1016/j.jpainsymman.2004.01.003.
23. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283(13):1710-4, http://dx.doi.org/10.1001/jama.283.13.1710.
24. Hudec R, Tisonova J, Bozekova L, Foltan V. Trends in consumption of opioid analgesics in Slovak Republic during 1998-2002. Eur J Clin Pharmacol. 2004;60(6):445-8, http://dx.doi.org/10.1007/s00228-004-0793-5.
25. Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007;19(1):25-30, http://dx.doi.org/10.1111/j.1742-6723.2006.00911.x.
26. Kaye KI, Welch SA, Graudins LV, Graudins A, Rotem T, Davis SR, et al. Pethidine in emergency departments: promoting evidence-based prescribing. Med J Aust. 2005;183(3):129-33.
27. O'Connor AB, Lang VJ, Quill TE. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med. 2005;118(8):885-9, http://dx.doi.org/10.1016/j.amjmed.2005.01.061.
28. Scudds RJ, Ostbye T. Pain and pain-related interference with function in older Canadians: the Canadian Study of Health and Aging. Disabil Rehabil. 2001;23(15):654-64, http://dx.doi.org/10.1080/09638280110043942.
29. Vallano A, Malouf J, Payrulet P, Banos JE. Analgesic use and pain in the hospital settings. Eur J Clin Pharmacol. 2007;63(6):619-26, http://dx. doi.org/10.1007/s00228-007-0303-7.
30. Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clin Ther. 2009;31(8):1859-70, http://dx.doi.org/10.1016/j.clinthera.2009.08.023.
31. Freye E, Levy JV. Use of opioids in the elderly-pharmacokinetic and pharmacodynamic considerations. Anasthesiol Intensivmed Notfallmed Schmerzther. 2004;39(9):527-37, http://dx.doi.org/10.1055/s-2004-825883.
32. Sadowski CA, Carrie AG, Grymonpre RE, Metge CJ, St John P. Access and intensity of use of prescription analgesics among older Manitobans. Can J Clin Pharmacol. 2009;16(2):e322-30.
33. Morley-Forster PK, Clark AJ, Speechley M, Moulin DE. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Res Manag. 2003;8(4):189-94.
34. Jarlbaek L, Andersen M, Hallas J, Engholm G, Kragstrup J. Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage. 2005;29(4):336-43, http://dx.doi.org/10.1016/j.jpainsymman.2004.07.010.
35. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med. 1993;119(8):844-50.